Botulinum toxin for provoked vestibulodynia. [PDF]
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: The primary objective is to examine the efficacy of botulinum toxin therapy in the treatment of provoked vestibulodynia (PVD) compared with placebo or no treatment.
Kim S +3 more
europepmc +3 more sources
Efficacy of transcranial direct-current stimulation (tDCS) in women with provoked vestibulodynia: study protocol for a randomized controlled trial. [PDF]
: Background: Provoked vestibulodynia is the most common form of vulvodynia. Despite its high prevalence and deleterious sexual, conjugal, and psychological repercussions, effective evidence-based interventions for provoked vestibulodynia remain limited.
Morin A +6 more
europepmc +3 more sources
Health and socioeconomic well-being of women with endometriosis and provoked vestibulodynia: Longitudinal insights from Swedish registry data. [PDF]
Endometriosis and provoked vestibulodynia (PVD) are prevalent pain conditions among women of reproductive age, significantly impacting their quality of life and psychological well-being.
Hanna Mühlrad +4 more
doaj +4 more sources
Treatment of Vestibulodynia with Submucosal Injections of IncobotulinumtoxinA into Targeted Painful Points: An Open-Label Exploratory Study [PDF]
The studies carried out to date on vulvodynia treatment with botulinum neurotoxin type A (BoNT/A) have followed generic injection protocols and reported contradictory outcomes on its effects.
Paula Villa-Muñoz +4 more
doaj +2 more sources
Partner responses to pain among male partners of women with provoked vestibulodynia—a cross-sectional study [PDF]
. Introduction:. Provoked vestibulodynia (PVD) is a prevalent persistent pain disorder, localized to the vulva, not only affecting the sexual health of women suffering from it but also of their partners.
Linn Myrtveit-Stensrud +7 more
doaj +2 more sources
Symptom-associated alterations in functional connectivity in primary and secondary provoked vestibulodynia. [PDF]
Primary provoked vestibulodynia (PVD) is marked by the onset of symptoms at first provoking vulvar contact, whereas secondary PVD refers to symptom onset after some period of painless vulvar contact. Different pathophysiological processes are believed to
Oughourlian TC +7 more
europepmc +3 more sources
Immune activation enhances epithelial nerve growth in provoked vestibulodynia [PDF]
BACKGROUND: Provoked vestibulodynia manifests as allodynia of the vulvar vestibular mucosa. The exact mechanisms that result in altered pain sensation are unknown.
Kalso, Eija +5 more
core +5 more sources
#ItsNotInYourHead: A Social Media Campaign to Disseminate Information on Provoked Vestibulodynia. [PDF]
Abstract Provoked Vestibulodynia (PVD) is a type of localized vulvodynia (or pain in the vulva). The estimated prevalence of this condition is about 12% of the general population and approximately 20% of women under the age of 19. Many women who live with PVD suffer in silence for years before receiving a diagnosis.
Brotto LA, Nelson M, Barry L, Maher C.
europepmc +4 more sources
Clinical impacts of botulinum toxin type A injections for provoked vestibulodynia: insights from randomized controlled trials [PDF]
Background Provoked vestibulodynia (PVD) is a chronic vulvar pain condition often associated with pelvic floor muscle hypertonicity. Botulinum neurotoxin type A (BoNT-A), a neuromuscular transmission blocker, has been proposed as a potential treatment to
Zhengyu Gao +3 more
doaj +2 more sources
Efficacy of transcranial direct-current stimulation in women with provoked vestibulodynia [PDF]
(Abstracted from Am J Obstet Gynecol 2017;216(6):584.e1–584.e11) The most frequent cause of premenopausal dyspareunia is provoked vestibulodynia (PVD). Patients with PVD have acute recurrent pain at the vaginal entrance in response to attempted vaginal penetration or application of pressure.
Guillaume Leonard +2 more
exaly +5 more sources

